The emergence of generic imatinib represents a significant opportunity for patients battling chronic myeloid leukemia and other diseases. Original brand-name imatinib, commonly known as Gleevec, carries a high price https://imatinib-400-mg106069.vidublog.com/42135868/common-sti571-a-budget-friendly-alternative